SEC Filings | Decibel Therapeutics, Inc.

Filing date	Form	Description	View
March 1, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-21-029968.pdf 0001104659-21-029968.rtf 0001104659-21-029968.xls View HTML
January 13, 2017	D/A	Amend: Notice of Exempt Offering of Securities	0001656536-17-000002.pdf 0001656536-17-000002.rtf View HTML
January 28, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-21-020896.pdf 0001193125-21-020896.rtf 0001193125-21-020896.xls View HTML
February 3, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-21-027403.pdf 0001193125-21-027403.rtf 0001193125-21-027403.xls View HTML
February 8, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-21-031447.pdf 0001193125-21-031447.rtf 0001193125-21-031447.xls View HTML
January 12, 2021	DRS/A	Amendment to a previously filed DRS	0000950123-21-000285.pdf 0000950123-21-000285.rtf 0000950123-21-000285.xls View HTML
February 19, 2021	3/A	An amendment to a 3 filing. Non-EDGAR filing	0000899243-21-007428.pdf 0000899243-21-007428.rtf 0000899243-21-007428.xls View HTML
March 29, 2021	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-21-016167.pdf 0001564590-21-016167.rtf 0001564590-21-016167.xls View HTML
January 27, 2021	CORRESP	CORRESP	0001193125-21-019328.pdf 0001193125-21-019328.rtf 0001193125-21-019328.xls View HTML
February 9, 2021	CORRESP	CORRESP	0001193125-21-034326.pdf 0001193125-21-034326.rtf 0001193125-21-034326.xls View HTML

Data provided by Kaleidoscope.

Main Corporate Nav